CClinicalTrials.gg
RecruitingNCT04046562PAWUpdated Jul 1, 2026

Pain and Weight Treatment: Development and Trial of PAW

An interventional study of PAW and Pain Education in Obesity, Adolescent, Pain, Chronic and CBT, sponsored by Connecticut Children's Medical Center. Recruiting at 1 site in United States. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Connecticut Children's Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will generate results that can be translated into immediate improvements in care for families seeking treatment for pediatric obesity.

Read the detailed description

Childhood obesity is a major public health crisis in the United States, affecting 16.9% of youth aged 2-19 and 20.5% of youth aged 12-19. While current family-based interventions are effective in reducing body mass index (BMI) in adolescents; the majority of adolescents regain their excess weight within 2 years. In addition, there is a high rate of drop out from weight management programs, with 27% to 73% of families not completing the full treatment protocol. One possible mechanism influencing pediatric weight management outcomes is chronic pain. Although chronic pain affects 25 to 46% of all youth, among youth with obesity, the prevalence is upwards of 70%. The causal relationship between pain and obesity is not well understood. In some cases, chronic pain may be a precipitant that causes youth to develop obesity by limiting their activities or altering their eating habits. A more common scenario is that obesity places mechanical stresses on the body that can cause pain. With time, pain may become "centralized." Either mechanism may impact youth's participation in a weight management program. However, interventions that address the relationship between chronic pain and obesity in youth are needed, yet no such interventions exist. The investigators expect that co-treating these conditions -obesity and pain- rather than treating just the obesity, will lead to improved pediatric weight management outcomes. The proposed study will take place at the Pediatric Obesity Center at Connecticut Children's Medical Center (CCMC), as an adjunct to our Fit5 program. Fit5 is CCMC's family-based, group weight management treatment program for youth between the ages of 10-18. Consisting of 13 sessions, this multidisciplinary program focuses on behavior changes, nutrition education and physical activity within a cognitive behavioral therapy (CBT) framework. A brief 4 session adjunctive CBT intervention, Pain and Weight treatment (PAW), will be trialed in a group of youth entering weight management treatment and endorsing musculoskeletal pain. This will be done in three phases. First a focus group will be held to review the PAW curriculum which has already been created for this study. In phase two, a small randomized (n = 25 per condition) controlled trial (RCT) will be conducted to pilot PAW. Finally, exit interviews to obtain preliminary feasibility, acceptability and retention data on PAW as compared to an information only control condition will be conducted. There is much work that continues to be needed to improve treatment for youth with obesity. The findings of this study will advance a line of research much needed to better understand outcomes and treatment for adolescents with obesity by shifting from focusing on obesity as an independent condition, and instead, treating it in the context of its comorbid conditions that may be important determinants of engagement, adherence, and outcomes. This proposal will focus on pain and obesity as a model with the intention that this could expand to other comorbidities such as sleep disturbances. The pilot data obtained through this R21 grant proposal will be used to modify the intervention and to seek R01 funding to support a large scale RCT of PAW.

02

Conditions studied

  • Obesity, Adolescent
  • Pain, Chronic
  • CBT
03

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Males and females between 12 and 18 years of age
  • Ability to speak, write and read English
  • A parent or guardian who speaks, writes and reads English
  • Signed consent and assent from the child and parent
  • Enrollment in a weight management program
  • Score greater than 3 on the Pain Burden Inventory at screening (in order to recruit adolescents who experience more than just general aches and pains).
  • Youth reporting musculoskeletal pain

Exclusion criteria

Exclusion Criteria:

  • Parent or guardian unable to participate
  • Patients on weight reducing medications
  • Severe psychiatric illness (i.e., suicidal or hospitalization within past 6 months)
  • Medical conditions such as Type 1 diabetes
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    PAW plus standard of care

    Each PAW session will include handouts and worksheets to assist with new strategies as well as homework. Strategies taught within PAW will be integrated with the skills taught in weight management. For example, pain diaries will be kept along with food and exercise logs to examine relationships among pain, eating and activity.

    Behavioral: PAW

  • Placebo comparator
    Pain education plus standard of care

    For those randomized into the information-only group, sessions will be delivered in the same manner. Sessions will cover general pediatric pain management but no behavioral or cognitive skills training will be taught.

    Behavioral: Pain Education

Interventions

  • BehavioralPAW

    Pain and Weight Treatment plus standard of care

  • BehavioralPain Education

    Pain Education plus standard of care

05

What researchers measure

Primary outcomes

  1. Mean difference in session attendance between groups

    The number of sessions of fit5 attended will be compared between the group attending PAW and those in the information control group.

    Time frame: Through the 13 weeks that comprise fit5

Secondary outcomes

  1. The feasibility and acceptability of the PAW intervention will be examined Via exit interviews

    At the exit interviews, the investigators will inquire with families whether 4 sessions felt sufficient, whether they would have liked more or less sessions and when they would have liked sessions scheduled.

    Time frame: At the conclusion of the 13 weeks of the program

  2. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Depressed mood: The Center for Epidemiological Studies Depression Scale for Children (CES-DC)

    Time frame: At the conclusion of the 13 weeks of the program

  3. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Eating behaviors (EAH): Three Factor Eating Questionnaire - R18

    Time frame: At the conclusion of the 13 weeks of the program

  4. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Pain symptoms: The Pain Frequency - Severity - Duration Scale

    Time frame: At the conclusion of the 13 weeks of the program

  5. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Pain symptoms: The Adolescent Pediatric Pain Tool

    Time frame: At the conclusion of the 13 weeks of the program

  6. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Self-confidence: Readiness Ruler

    Time frame: At the conclusion of the 13 weeks of the program

  7. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Eating behaviors: Eating Behaviors Questionnaire

    Time frame: At the conclusion of the 13 weeks of the program

  8. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Behavior: The Pediatric Symptom Checklist 17 item (PSC-17)

    Time frame: At the conclusion of the 13 weeks of the program

  9. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Quality of life: Sizing me up

    Time frame: At the conclusion of the 13 weeks of the program

  10. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Quality of life: Sizing them up

    Time frame: At the conclusion of the 13 weeks of the program

  11. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Pain symptoms: The Child Activity Limitations Interview questionnaire

    Time frame: At the conclusion of the 13 weeks of the program

  12. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Pain symptoms: The Child Activity Limitations Interview questionnaire Parent version

    Time frame: At the conclusion of the 13 weeks of the program

  13. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Pain symptoms: Pain Burden Interview

    Time frame: At the conclusion of the 13 weeks of the program

  14. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Sleep: Adolescent Sleep-Wake Scale

    Time frame: At the conclusion of the 13 weeks of the program

  15. The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.

    Although not powered to be able to detect clinically significant differences pre and post program completion, as part of standard of care families complete a battery of measures prior to and after their completion in the fit5 program. Family scores on these responses will be examined to see if trends show changes in a meaningful and clinically relevant direction. Medical: Youth will have their height, weight, BMI and BMI z-score calculated pre and post program completion as well as an assessment of their medical comorbidities.

    Time frame: At the conclusion of the 13 weeks of the program

06

Study locations

1 of 1 sites recruiting
  • Connecticut Children's Medical Center
    Hartford, Connecticut 06106, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — NA - the investigators are not planning on sharing the data

08

Registry details

Key details

Study ID
NCT04046562
Lead sponsor
Connecticut Children's Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Melissa Santos (Principal Investigator, Connecticut Children's Medical Center) — Principal investigator
First posted
Aug 6, 2019
Start date
Aug 14, 2019
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jul 1, 2026

Study contacts

Melissa Santos, PhD
Contact
Msantos@connecticutchildrens.org
860-837-6739
Melissa Santos, PhD
principal investigator · Connecticut Children's Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion